Adial Pharmaceuticals Other Current Liabilities

Adial Pharmaceuticals (ADIL) currently reports a other current liabilities of $940K as of March 2026. That compares with $260K in the prior-year period — up 260.7% year over year. Use the charts on this page to explore Adial Pharmaceuticals's other current liabilities history and peer comparisons.

Adial Pharmaceuticals's other current liabilities increased from $260K to $940K — a 260.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Adial Pharmaceuticals reported $940K in other current liabilities as of March 2026. That compares with $260K in the prior-year period — up 260.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $940K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Adial Pharmaceuticals, and consider following ADIL for alerts when major investors trade the stock.

Adial Pharmaceuticals is classified in the Healthcare sector. On other current liabilities, it currently shows $940K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ADIL with unrelated industries.